Stay updated with breaking news from Oblte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares shot up 5.2% during trading on Tuesday . The stock traded as high as $30.00 and last traded at $30.00. 1,118 shares were traded during mid-day trading, a decline of 89% from the average session volume of 10,525 shares. The stock had previously closed at $28.51. Wall […]
Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Rating) dropped 4.6% during trading on Monday . The stock traded as low as $28.51 and last traded at $28.51. Approximately 1,999 shares traded hands during trading, a decline of 81% from the average daily volume of 10,531 shares. The stock had previously closed at $29.90. Analysts […]
Belite Bio, Inc (NASDAQ:BLTE – Get Rating)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $28.20, but opened at $24.92. Belite Bio shares last traded at $22.23, with a volume of 805 shares trading hands. About Belite Bio (NASDAQ:BLTE) Belite Bio, Inc, a clinical-stage biopharmaceutical drug development […]
Belite Bio’s (NASDAQ:BLTE – Get Rating) quiet period is set to expire on Wednesday, June 8th. Belite Bio had issued 6,000,000 shares in its public offering on April 29th. The total size of the offering was $36,000,000 based on an initial share price of $6.00. During Belite Bio’s quiet period, underwriters and any insiders involved […]
Belite Bio, Inc. (BLTE) is planning to raise $36 million in an IPO on Friday, April 29th, IPO Scoop reports. The company will issue 6,000,000 shares at a price of $5.50-$6.50 per share. Belite Bio, Inc. has a market-cap of $144.6 million. The Benchmark Company acted as the underwriter for the IPO. Belite Bio, Inc. […]